A Prospective Cohort Study of Clinical and Process Outcomes of Older Adults That Transition Through the Geriatric Emergency Medicine Unit(GEM-U)

November 14, 2025 updated by: University of Limerick

A Prospective Cohort Study of the Clinical and Process Outcomes of Older Adults That Transition Through the Geriatric Emergency Medicine Unit (GEM-U)

This study will characterise the patients using the Geriatric Emergency Medicine Unit, a unit which provides specialist care for patients aged 75 years and older attending the emergency department. It will examine how this specialist care impacts their health in terms of a number of different outcomes, such as; function, quality of life and health care usage; for example admission to the acute hospital.

Study Overview

Status

Recruiting

Conditions

Detailed Description

The emergency department is a particularly challenging and busy environment, particularly for older adults living with frailty. It is widely acknowledged throughout the literature and national healthcare strategy that these older adults require holistic, person centred care that targets the intricacies of multifaceted, complex health issues.

The geriatric emergency medicine unit (GEM-U) aims to provide such care through the framework of comprehensive geriatric assessment, with in-put from a team of healthcare disciplines. The main aim of this study is to look at how this specialist care impacts patient outcomes, such as acute admission. Clinical and process outcomes of participants will be examined using patient reported outcome measures, which will include;

  1. Global measure of function (Barthel Index)
  2. Delirium screen (4AT +/- Delirium Rating Scale)*
  3. Frailty status (Clinical Frailty Scale)
  4. Nutritional status (Mini Nutritional Assesment)
  5. Quality of life (EuroQoL-5D-5L).
  6. Patient satisfaction (PSQ-18).

Participants will be followed at 30 days and 6 months post recruitment. All participants will give fully informed consent. The STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) standardised reporting guidelines will be followed in the conduct and reporting of this research. Data will be statistically analysed

Study Type

Observational

Enrollment (Estimated)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

All prospective older adults attending the GEMU that meet inclusion criteria will be invited to participate. However, this will be limited to the working hours of the research team (Monday-Friday, 8:00-20:00).

Description

Inclusion Criteria:

  • Older adults aged ≥75 years
  • Manchester Triage System category 2-5
  • Screen positive for risk of adverse outcomes after ED visit (≥ 2 on ISAR screening tool)
  • Presenting with a medical condition
  • Reviewed by the Older Persons Integrated Care Team

Exclusion Criteria:

  • Patients presenting with a non-medical issue including major trauma or hip fracture

    • Patients presenting with acute stroke or transient ischaemic attack
    • Patients more appropriate to another alternative pathway e.g. deep vein thrombosis pathway, low risk chest pain pathway
    • Patients with acute coronary syndrome or unstable arrthymia
    • Patients requiring care in the resuscitation room
    • Patients with head injury (unless appropriate assessment and management has been fully completed by ED team)
    • Patients with possible spinal injury (unless appropriate assessment and management has been fully completed by ED/orthopaedic team)
    • Patients with low Glasgow Coma Scale
    • Other exclusions at the discretion of the Older Persons Integrated Care team depending on team capacity and expertise
    • Exclusion criteria as set out above, are in line with those set out in the UHL Operating Policy of the Older Persons Integrated Care Team.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Our primary outcome is incidence of hospital admission at index GEM-U presentation
Time Frame: Patients are followed at 30 days and 6 months
Patients who attend GEM-U and have an acute hospital admission at this time
Patients are followed at 30 days and 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mortality
Time Frame: Patients are followed at 30 days and 6 months
Mortality
Patients are followed at 30 days and 6 months
Unscheduled ED revisit
Time Frame: Patients are followed at 30 days and 6 months
Patients who attend the ED department again during the follow up period
Patients are followed at 30 days and 6 months
Unscheduled hospital visit(s)
Time Frame: Patients are followed at 30 days and 6 months
Patients who have unplanned hospital admission (i.e. not elective procedure) during follow up period
Patients are followed at 30 days and 6 months
Nursing home admission
Time Frame: Patients are followed at 30 days and 6 months
Patients now living in a nursing home
Patients are followed at 30 days and 6 months
Healthcare utilization (GP visit, out-patient geriatric services, PHN visit, HSCP services)
Time Frame: Patients are followed at 30 days and 6 months
Use of primary care and community care services
Patients are followed at 30 days and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ida Carroll, University of Limerick

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 10, 2025

Primary Completion (Estimated)

March 30, 2026

Study Completion (Estimated)

March 30, 2026

Study Registration Dates

First Submitted

November 14, 2025

First Submitted That Met QC Criteria

November 14, 2025

First Posted (Actual)

November 19, 2025

Study Record Updates

Last Update Posted (Actual)

November 19, 2025

Last Update Submitted That Met QC Criteria

November 14, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • GEM-U2025

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Frailty

Subscribe